Torrent Pharmaceuticals Limited shareholders approved a total dividend of ₹38 per equity share for the financial year ended March 31, 2026, at its 53rd Annual General Meeting held on June 23, 2026. The meeting, conducted via video conferencing, saw the adoption of standalone and consolidated financial statements and the ratification of cost auditors' remuneration. The voting results were declared by the Scrutinizer, Rajesh Parekh of RPAP & Co., confirming approval across all resolutions.

The company confirmed the payment of an interim dividend of ₹29.00 per equity share and declared a final dividend of ₹9.00 per equity share. Both dividends are applicable on shares with a fully paid-up face value of ₹5.00 each. Shareholders also ratified the remuneration of cost auditors for the fiscal year 2026-27 and approved the issuance of equity shares, which may include convertible bonds or debentures.

Voting Outcomes

The resolutions were passed through remote e-voting, which was open from June 19 to June 22, 2026, and e-voting conducted during the meeting. The proceedings were conducted in compliance with the Companies Act, 2013, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

A notable block trade was recorded on the National Stock Exchange (NSE) for Torrent Pharmaceuticals , with approximately 60,044 shares changing hands in a single transaction. The trade was executed at a price of ₹4475.00 per share, aggregating to a total deal value of ₹26.87 crores.

Block Trade Details

The following table summarizes the key parameters of the block trade recorded on the NSE:

Significance of Block Trades

Block trades are large-volume transactions typically executed by institutional investors or high-net-worth participants, often outside the regular order book to minimize market impact. The execution of such a trade in Torrent Pharmaceuticals on the NSE underscores notable institutional activity in the stock at the stated price level.